IDEXX Laboratories said on February 13, 2026 it received notice from director M. Anne Szostak of her intention to retire from the Board effective immediately following the 2026 Annual Meeting of Stockholders to be held on May 12, 2026.

1. 01

   IDEXX Laboratories said on February 13, 2026 it received notice from director M. Anne Szostak of her intention to retire from the Board effective immediately following the 2026 Annual Meeting of Stockholders to be held on May 12, 2026.

2. 02

   The company said Szostak's decision to retire from the Board does not arise from any disagreement with the company or the Board on any matter relating to the company's operations, policies, practices or otherwise.

3. 03

   IDEXX Laboratories said Szostak has served as a member of the Board since 2012 and thanked her for her extraordinary service, contributions and leadership during her tenure.

4. 04

   The company said that in accordance with its amended and restated by-laws, the Board reduced the size of Class III effective upon Szostak's retirement from the Board, but did not reduce the size of the Board in light of the previously announced appointment of Michael G. Erickson, PhD, as a Class II member of the Board.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.